|
Volumn 436, Issue 7050, 2005, Pages 485-
|
India's drug tests
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COST EFFECTIVENESS;
DRUG PRODUCTS PLANTS;
DRUG COMPANIES;
DRUG TESTS;
DRUG DOSAGE;
ANTINEOPLASTIC AGENT;
LETROZOLE;
OUTSOURCING;
PHARMACEUTICAL INDUSTRY;
CLINICAL TRIAL;
COST MINIMIZATION ANALYSIS;
DRUG INDUSTRY;
DRUG SCREENING;
DRUG SURVEILLANCE PROGRAM;
HUMAN;
INDIA;
INFERTILITY;
MEDICAL ETHICS;
MEDICAL PRACTICE;
PRIORITY JOURNAL;
SHORT SURVEY;
ANIMAL;
ARTICLE;
COST;
ECONOMICS;
MEDICAL RESEARCH;
POPULATION DENSITY;
PRACTICE GUIDELINE;
STANDARD;
ASIA;
EASTERN HEMISPHERE;
EURASIA;
INDIA;
SOUTH ASIA;
WORLD;
NELUMBO NUCIFERA;
ANIMALS;
ANTINEOPLASTIC AGENTS;
BIOMEDICAL RESEARCH;
CLINICAL TRIALS;
COSTS AND COST ANALYSIS;
DRUG INDUSTRY;
HUMANS;
INDIA;
POPULATION DENSITY;
PRACTICE GUIDELINES;
|
EID: 23444459852
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/436485a Document Type: Short Survey |
Times cited : (9)
|
References (0)
|